Jump to content
Search In
Find results that contain...
Find results in...

Recommended Posts

Bradley Pharmaceuticals Launches Kerol Topical Suspension and ROSULA® Clarifying Wash

June 28, 2007: 07:45 AM EST

FAIRFIELD, N.J., June 28 /PRNewswire-FirstCall/ -- Bradley Pharmaceuticals, Inc. today announced that its Doak Dermatologics subsidiary recently launched two new product line extensions from its Kerol and ROSULA® brand portfolios.

Kerol Topical Suspension (50% Urea), a potent keratolytic in a vehicle containing lactic acid & salicylic acid, is an addition to the line of Kerol Redi-Cloths keratolytic moisturizers. Kerol Topical Suspension is indicated for the treatment of hyperkeratotic conditions such as dry, rough skin, dermatitis, psoriasis, xerosis, ichthyosis, eczema, keratosis pilaris, keratosis palmaris, keratoderma, corns and calluses.

ROSULA® Clarifying Wash (sodium sulfacetamide 10% and sulfur 4%) is the fourth product launched under the ROSULA® brand. The new ROSULA® Clarifying Wash formulation combines 10% sodium sulfacetamide and 4% sulfur in a urea vehicle and is indicated for the treatment of acne vulgaris, acne rosacea and seborrrheic dermatitis. Bradley launched the ROSULA® brand in 2003 with ROSULA® Aqueous Gel which was followed by ROSULA® Aqueous Cleanser and ROSULA® NS Medicated Pads.

"Our Kerol and ROSULA® brands have been well received by physicians and patients and we anticipate that these new therapies will likewise be well received," stated Daniel Glassman, President and CEO of Bradley Pharmaceuticals. "One important part of our business strategy is to develop brands through life cycle management that add value to the medical community and patient care, and we believe that Kerol Topical Suspension and ROSULA® Clarifying Wash both will meet this objective."

Important Product Safety Information About Kerol Topical Suspension:

KEROL Topical Suspension is for external use only. Avoid contact with eyes, lips or mucous membranes. If redness or irritation occurs, discontinue use.

Important Product Safety Information About ROSULA® Clarifying Wash:

ROSULA® Clarifying Wash is contraindicated in persons with known or suspected hypersensitivity to sulfonamides or sulfur. ROSULA® Clarifying Wash is not to be used by patients with kidney disease. Although rare, topical sodium sulfacetamide may cause local irritation.

For additional important information about Kerol Topical Suspension or ROSULA® Clarifying Wash please view full prescribing information at www.bradpharm.com or request full prescribing information by contacting Bradley Pharmaceuticals at 973-882-1505.

Share this post

Link to post
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Personalized Advice Quiz - All of Acne.org in just a few minutes